TScan Therapeutics
TCRX
#7916
Rank
C$0.29 B
Marketcap
$5.51
Share price
0.00%
Change (1 day)
-3.75%
Change (1 year)

Earnings for TScan Therapeutics (TCRX)

Earnings in 2024 (TTM): -C$0.15 Billion

According to TScan Therapeutics's latest financial reports the company's current earnings are C$12.2 Million. In 2023 the company made an earning of -C$0.13 Billion a decrease over its 2022 earnings that were of -C$92.66 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for TScan Therapeutics from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.15 Billion13.31%
2023 -C$0.13 Billion34.73%
2022 -C$92.66 Million36.19%
2021 -C$68.04 Million86.11%
2020 -C$36.56 Million